Helping The others Realize The Advantages Of iMDK
All enrolled clients who received a minimum of just one dose of zosuquidar or placebo all through induction had been monitored to the prevalence of adverse events (439 clients, 219 on zosuquidar and 210 on placebo). The most common adverse functions were linked to the period of extended and significant myelosuppression as is anticipated with induct